drugset / Trial / NCT01745770
TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the trial is to proof whether TID 1000 mg mesalazine is non-inferior to TID 2x 500 mg mesalazine in the treatment of patients with acute ulcerative colitis
Timeline
- Start
- 2013-01
- Primary completion
- 2015-03
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesalamine | Small molecule | 500 mg | Oral |
| Subject | Mesalamine | Small molecule | 1000 mg | Oral |